Literature DB >> 32943468

Exercise interventions in metastatic cancer disease: a literature review and a brief discussion on current and future perspectives.

Michal Wilk1, Jaroslaw Kepski2, Justyna Kepska3, Stephen Casselli4, Sebastian Szmit3.   

Abstract

Exercise is a well-established factor which improves outcomes of oncological patients during curative treatment as well as in cancer survivors. However, the role of physical activity in metastatic disease, due to the deficiency of high-level evidence from prospective clinical trials, remains a partially unexplored field of research. Additionally, no specific guidelines related to exercise for persons with advanced cancer have been developed so far. Unfortunately, this research deficit may effectively prevent physicians from prescribing adequate and safe recommendations on physical activity to their patients. In an attempt to fill this gap in clinical practice, we present here an up-to-date review of potential benefits of exercise interventions in relation to the survival, quality of life and supportive care for patients with metastatic cancer. We also review the data on the safety of physical activity with special emphasis on elderly populations or individuals with bone metastases. Finally, we discuss the most relevant clinical factors that should be considered during exercise qualification. In conclusion, physical activity is an important tool for improving the outcomes of people undergoing anticancer therapy for metastatic disease. However, the training should be tailored individually to the patient's functional status, comorbidities and preferences. Physical activity should become a standard component of every metastatic cancer care plan. © Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  cancer; clinical assessment; quality of life; rehabilitation; supportive care

Year:  2020        PMID: 32943468     DOI: 10.1136/bmjspcare-2020-002487

Source DB:  PubMed          Journal:  BMJ Support Palliat Care        ISSN: 2045-435X            Impact factor:   3.568


  7 in total

Review 1.  Interventions to Reduce Sedentary Behavior in Cancer Patients and Survivors: a Systematic Review.

Authors:  Britni R Belcher; Dong-Woo Kang; Alexandra G Yunker; Christina M Dieli-Conwright
Journal:  Curr Oncol Rep       Date:  2022-07-13       Impact factor: 5.945

Review 2.  Rehabilitation in Advanced Cancer Patients with Bone Metastases and Neural Compromise: Current Status and Future Directions.

Authors:  Cho Rong Bae; Ma Nessa Gelvosa; Jae Yong Jeon
Journal:  Curr Oncol Rep       Date:  2022-04-01       Impact factor: 5.945

3.  Baseline Electrocardiographic and Echocardiographic Assessment May Help Predict Survival in Lung Cancer Patients-A Prospective Cardio-Oncology Study.

Authors:  Sabina Mędrek; Sebastian Szmit
Journal:  Cancers (Basel)       Date:  2022-04-15       Impact factor: 6.575

4.  Physical activity in older adults with metastatic gastrointestinal cancer: a pilot and feasibility study.

Authors:  Justin C Brown; Elizabeth Brighton; Nancy Campbell; Nadine J McCleary; Thomas A Abrams; James M Cleary; Peter C Enzinger; Kimmie Ng; Douglas Rubinson; Brian M Wolpin; Matthew B Yurgelun; Jeffrey A Meyerhardt
Journal:  BMJ Open Sport Exerc Med       Date:  2022-05-30

Review 5.  Mechanobiology of Bone Metastatic Cancer.

Authors:  Blayne A Sarazin; Claire L Ihle; Philip Owens; Maureen E Lynch
Journal:  Curr Osteoporos Rep       Date:  2021-11-03       Impact factor: 5.096

6.  Effect of acute aerobic exercise before immunotherapy and chemotherapy infusion in patients with metastatic non-small-cell lung cancer: protocol for the ERICA feasibility trial.

Authors:  Manon Gouez; Olivia Pérol; Maurice Pérol; Christophe Caux; Christine Ménétrier-Caux; Marine Villard; Thierry Walzer; Lidia Delrieu; Pierre Saintigny; Philippe Marijnen; Vincent Pialoux; Béatrice Fervers
Journal:  BMJ Open       Date:  2022-04-07       Impact factor: 2.692

Review 7.  Tailoring the Evidence for Exercise Oncology within Breast Cancer Care.

Authors:  Chad W Wagoner; Lauren C Capozzi; S Nicole Culos-Reed
Journal:  Curr Oncol       Date:  2022-07-09       Impact factor: 3.109

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.